Novo Integrated Sciences EBIT 2012-2024 | NVOS

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Integrated Sciences ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Novo Integrated Sciences ebit from 2012 to 2024. Ebit can be defined as earnings before interest and taxes.

Related Stocks
Company Name	Market Cap
Fresenius SE (FSNUY)	$21.4B
Quest Diagnostics (DGX)	$18.2B
DaVita (DVA)	$14.4B
Encompass Health (EHC)	$10B
Chemed (CHE)	$8.5B
Elanco Animal Health (ELAN)	$5.9B
Option Care Health (OPCH)	$5.3B
RadNet (RDNT)	$4.8B
LifeStance Health (LFST)	$3B
Amedisys (AMED)	$3B
Addus HomeCare (ADUS)	$2.3B
Astrana Health (ASTH)	$2.1B
U.S Physical Therapy (USPH)	$1.3B
Pennant (PNTG)	$909M
Aveanna Healthcare Holdings (AVAH)	$889M
Atai Life Sciences (ATAI)	$260M
Bioqual (BIOQ)	$55M
Daxor (DXR)	$37M
Ontrak (OTRK)	$7M
MEDIROM Healthcare Technologies (MRM)	$5M
IMAC Holdings (BACK)	$1M
Psychemedics (PMD)	$0M